Electronic Consent: Website Guidance & Memo for Sponsors

Updated March 2025: Please refer to the Electronic Consent Guidance for current information. Secure electronic signature platforms may be used for all studies, including FDA-regulated trials. Researchers are responsible for ensuring that the selected platform complies with all applicable regulations.

The UCSF Human Research Protection Program and Office of Research leadership have developed guidance (retired page) on using DocuSign and REDCap to obtain electronic signatures for research consent and HIPAA authorization during the COVID-19 public health emergency.